A detailed history of Catalyst Funds Management Pty LTD transactions in Beyond Air, Inc. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 6,000 shares of XAIR stock, worth $2,760. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,000
Holding current value
$2,760
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.36 - $0.64 $2,160 - $3,840
6,000 New
6,000 $2.33 Million
Q1 2024

Dec 04, 2024

SELL
$1.3 - $2.15 $5,467 - $9,042
-4,206 Reduced 70.1%
1,794 $3.12 Million

Others Institutions Holding XAIR

About Beyond Air, Inc.


  • Ticker XAIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 29,888,000
  • Market Cap $13.7M
  • Description
  • Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...
More about XAIR
Track This Portfolio

Track Catalyst Funds Management Pty LTD Portfolio

Follow Catalyst Funds Management Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalyst Funds Management Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Catalyst Funds Management Pty LTD with notifications on news.